Background: Atrial septal openings (ASOs) are very common in premature infants. Objective: The study aimed to evaluate the prevalence and natural course of ASOs in very low birth weight (VLBW) infants diagnosed in the first week of life and the association of ASOs with various clinical factors. Methods: We retrospectively reviewed the medical records of 217 infants born with a weight of <1,500 g between January 2007 and December 2011. Echocardiography was conducted within the first week of life in all infants. Clinical factors were compared between infants with ASO and those with an intact atrial septum. ASO closure was confirmed by echocardiography at the 3-month follow-up and subsequently every 6 months. Results: The incidence of ASOs was 40.3% in VLBW infants. Patent ductus arteriosus (PDA) was associated with a higher incidence of ASO in a multivariate analysis (OR 4.005, 95% CI 2.015-7.960, p < 0.001), and PDA was a predictor of early ASO closure. The rate of oxygen requirement for at least 28 days was higher in infants with ASO, whereas oxygen dependency at 36 weeks' postmenstrual age did not differ between the infant groups. The mean time of closure was 5.8 ± 7.1 months of age (range 0-36). All followed infants showed spontaneous closure within 3 years. Conclusions: ASOs occur at a relatively high incidence in VLBW infants, but most of these close spontaneously within 3 years. PDA was predictive of ASO at the first echocardiography but did not delay ASO closure. The ASOs in VLBW infants were not a significant cause of concern.

Keywords:
Atrial septal defect, Bronchopulmonary dysplasia, Patent ductus arteriosus, Premature infants, Very low birth weight infant
1.
Shuler CO, Black GB, Jerrell JM: Population-based treated prevalence of congenital heart disease in a pediatric cohort. Pediatr Cardiol 2013;34:606-611.
2.
Christensen DD, Vincent RN, Campbell RM: Presentation of atrial septal defect in the pediatric population. Pediatr Cardiol 2005;26:812-814.
3.
Garne E, Olsen MS, Johnsen SP, Hjortdal V, Andersen HØ, Nissen H, Søndergaard L, Videbaek J: How do we define congenital heart defects for scientific studies? Congenit Heart Dis 2011;7:46-49.
4.
Meberg A, Otterstad JE, Frøland G, Lindberg H, Sørland SJ: Outcome of congenital heart defects - a population-based study. Acta Paediatr 2000;89:1344-1351.
5.
Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR: The epicure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106:659-671.
6.
Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
7.
Philip AG: Bronchopulmonary dysplasia: then and now. Neonatology 2012;102:1-8.
8.
Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-534.
9.
Dolk H, Loane M, Garne E: Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011;123:841-849.
10.
Popat H, Kluckow M: Noninvasive assessment of the early transitional circulation in healthy term infants. Neonatology 2012;101:166-171.
11.
Senocak F, Karademir S, Cabuk F, Onat N, Koc S, Duman A: Spontaneous closure of interatrial septal openings in infants: an echocardiographic study. Int J Cardiol 1996;53:221-226.
12.
Fukazawa M, Fukushige J, Ueda K: Atrial septal defects in neonates with reference to spontaneous closure. Am Heart J 1988;116:123-127.
13.
Hanslik A, Pospisil U, Salzer-Muhar U, Greber-Platzer S, Male C: Predictors of spontaneous closure of isolated secundum atrial septal defect in children: a longitudinal study. Pediatrics 2006;118:1560-1565.
14.
Azhari N, Shihata MS, Al-Fatani A: Spontaneous closure of atrial septal defects within the oval fossa. Cardiol Young 2004;14:148-155.
15.
Radzik D, Davignon A, van Doesburg N, Fournier A, Marchand T, Ducharme G: Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol 1993;22:851-853.
16.
Ozcelik N, Atalay S, Tutar E, Ekici F, Atasay B: The prevalence of interatrial septal openings in newborns and predictive factors for spontaneous closure. Int J Cardiol 2006;108:207-211.
17.
Garne E: Atrial and ventricular septal defects - epidemiology and spontaneous closure. J Matern Fetal Neonatal Med 2006;19:271-276.
18.
Riggs T, Sharp SE, Batton D, Hussey ME, Weinhouse E: Spontaneous closure of atrial septal defects in premature versus Full-term neonates. Pediatr Cardiol 2000;21:129-134.
19.
Lim DS, Matherne GP: Percutaneous device closure of atrial septal defect in a premature infant with rapid improvement in pulmonary status. Pediatrics 2007;119:398-400.
20.
Motz R, Grassl G, Trawoger R: Dependence on a respiratory ventilator due to an atrial septal defect. Cardiol Young 2000;10:150-152.
21.
McMahon CJ, Feltes TF, Fraley JK, Bricker JT, Grifka RG, Tortoriello TA, Blake R, Bezold LI: Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002;87:256-259.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.